---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-001969"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2025-04-01T23:59:59+00:00"
generated_at: "2026-05-24T01:08:21.196306+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics closes $3.9M registered direct offering and private placement

## Summary
- Gross proceeds ~$3.9M from sale of 3.325M shares at $0.65 and pre-funded warrants for 2.728M shares.
- Issued Series G warrants to purchase up to 6.053M shares at $0.6954, exercisable after 6 months for 7.5 years.
- Ladenburg Thalmann placement agent; 8% cash fee + 1% management; received warrants for 302,650 shares at $0.8125.
- Proceeds for working capital and to advance pre-clinical and clinical programs.
- Directors/officers subject to 90-day lock-up; company restricted from further issuances for 75 days (with exceptions).

## SEC filing metadata
- accession: 0001641172-25-001969
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2025-04-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000164117225001969/0001641172-25-001969-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000164117225001969/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-001969
- JSON: https://secwatch.observer/filing/0001641172-25-001969.json
- Plain text: https://secwatch.observer/filing/0001641172-25-001969.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.